Clinical Research Directory
Browse clinical research sites, groups, and studies.
Preemptive Intravenous Micro-dose Dexmedetomidine to Prevent Emergence Agitation in Adult Patients Undergoing Septoplasty Surgeries
Sponsor: Tanta University
Summary
This prospective randomized controlled study will be conducted to evaluate the effect of preoperative single, micro-dose of dexmedetomidine (0.3μg/kg) on the incidence and severity of EA in adults undergoing Septoplasty surgeries
Official title: Preemptive Intravenous Micro-dose Dexmedetomidine to Prevent Emergence Agitation in Adult Patients Undergoing Septoplasty Surgeries: A Randomized Placebo Controlled Study
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2026-01-10
Completion Date
2026-07-30
Last Updated
2025-12-24
Healthy Volunteers
No
Conditions
Interventions
Dexmedetomidine
micro dose of dexmedetomidine (0.3 µg /kg) in 50 ml 0.9% saline slow infusion over 10 minutes, 15 minutes before surgery.
Saline
50 ml 0.9% saline slow infusion over 10 minutes, 15 minutes before surgery.
Locations (1)
Tanta university
Tanta, Gharbia Governorate, Egypt